Urolithin A: The Promise and Reality of a Gut Metabolite

Urolithin A is a natural metabolite produced by gut bacteria that break down polyphenols in food. While there has been a significant amount of interest and hype around urolithin A supplements, we take a look at the reality to see if it measures up.

Life, longevity, and a bit of fruit juice

In the days when infections, injuries, and wild animals were the major causes of human mortality, making it to 40 was quite an achievement. Today, we routinely reach 80 years old, blowing out birthday candles most of our ancestors could only dream of [1].

This is in no small part due to advances in medicine. It allows us to survive diseases and injuries that would be fatal for humans in the past. However, despite our modern medicine, living longer is still not the same as living well.

Despite our advancements, older people still struggle with sore joints, poor eyesight, and memory issues. Modern healthcare is great at keeping the body alive but not necessarily at preventing it from gradually breaking down [2].

This has led to a grand scientific treasure hunt for something that can change that. Somewhere out there, we hope, lies a molecule, a mechanism, or perhaps just the right fruit juice that can help extend the “good years.”

One candidate is urolithin A, a molecule created from polyphenols found in fruit. It all starts with ellagic acid, a polyphenol abundant in various fruits [3]. The right gut bacteria, which are not present in everyone, convert these polyphenols into urolithin A.

Dietary sources of ellagic acid

So far, research has found multiple dietary sources of ellagic acid and/or ellagitannins [2, 3].

• Pomegranate
• Strawberries
• Raspberries
• Blackberries
• Camu-camu
• Walnuts
• Chestnuts
• Pistachios
• Pecans
• Tea
• Oak barrel-aged wines and spirits

The problem is that only about 40% of people have the right microbes to convert it. Of every five people drinking the same antioxidant-rich, pomegranate juice, only two reap the benefits [4].

This inconsistency has led researchers to a simple question: Why leave things to chance? If the gut is unreliable, why not take urolithin A directly?

Supplements flood the bloodstream with levels far beyond what diet alone could achieve. Here, there is no microbial assistance required; a single pill provides a direct biochemical expressway to the cells [5].

Early research hints at something tantalizing once this molecule reaches the bloodstream, muscles, and mitochondria. Urolithin A might offer a way to rejuvenate aging muscles, reduce inflammation, and slow the biological clock [5-7].

A story of ellagitannins

Every molecule has an origin story, and urolithin A’s journey starts with plants waging chemical warfare. A great many things are trying to eat the fruits and nuts of raspberry bushes, pomegranate trees, and walnut trees, including fungi, bacteria, and insects. Therefore, such plants load their tissues with defensive molecules called ellagitannins: complex, bitter compounds designed to deter hungry pests.

To a caterpillar, these are the botanical equivalent of razor wire [8]; to us humans, they’re just nutrients. Here’s where things get interesting; when you eat an ellagitannin-rich food, your stomach takes one look at these molecules and decides it wants nothing to do with them. Instead, they pass into the intestines, where gut bacteria get their shot.

A few microbes, such as Bifidobacterium pseudocatenulatum and Enterococcus faecium, are specialists in this area. They break down ellagitannins, liberating ellagic acid [9]. However, even if your gut has the right bacteria, they work less efficiently with age, which is when people need urolithin A the most.

Microbial populations shift over time, influenced by diet, lifestyle, and medications [10, 11]. By the time you’re old enough to care about other things declining, your gut’s microbiome is also in decline.

One of those other things is the mitochondria.

Aging of the cellular power plants

The failure of proper energy processing is a major aspect of aging. Cells do not suddenly stop working for dramatic effect. They become less effective at making and managing energy, and the culprits at the center of this breakdown are the mitochondria.

Mitochondria are small organelles that power every cell in the body. They work tirelessly converting food and oxygen into cellular energy [12, 13]. Everything from heartbeats to muscle contractions to cognitive function depends on mitochondria doing their job well.

Just like a power grid, when it begins to fail, you notice. Energy levels drop, muscles weaken, tissues become inflamed, and your whole system loses resilience over time [14].

Mitochondria are dynamic. They fuse, divide, and, when necessary, self-destruct through a highly regulated cleanup process called mitophagy. This is the cellular equivalent of decommissioning old, inefficient power plants and replacing them with newer, better-functioning ones.

When mitophagy runs smoothly, cells stay efficient, but aging slows this process down. Instead of getting neatly recycled, defective mitochondria accumulate, leaking harmful molecules, increasing inflammation, and generally making a mess of things.

This results in less energy, more oxidative stress, and a body that’s increasingly running on old, malfunctioning power plants [13]. The billion-dollar question is, then, whether we can do anything to reboot mitochondrial maintenance.

This is exactly where urolithin A enters the picture. In several studies, first in worms and rodents, and more recently in humans, urolithin A helps mitophagy. This process encourages cells to remove damaged mitochondria and create space for healthier ones [15, 16]. This is the equivalent of hiring an elite cleanup crew for cellular power plants.

In animal studies, urolithin A improves endurance, enhances mitochondrial function, and even extends lifespan. Urolithin A has profound effects on middle-aged mice. Muscle fibers look rejuvenated, endurance skyrockets, and mitochondria start behaving like they did in younger mice. It’s a geroscience dream: their mitochondria start looking and acting younger [16].

In humans, the effects are more subtle but still promising. Studies have found enhanced mitochondrial gene expression, improved muscle endurance, and reduced markers of inflammation [17]. While the effects are not drastic, urolithin A clearly helps aging cells to improve.

Unlike some treatments that increase the number of mitochondria, urolithin A focuses on improving their quality. Instead of adding more power plants to the grid, it is shutting down the old, failing ones. This allows the working plants to run at full capacity [18].

This is why researchers are intrigued. If one metabolite from the gut can help keep mitochondria healthy as we age, it may protect muscle function and brain health.

The implications here are significant not just for athletic performance but for longevity and age-related diseases. When mitochondria fail, it’s not just about feeling tired, it’s about the slow erosion of vitality itself.

Which brings us to the next big question: does all this translate into better muscle function as we age?

Muscle health and strength

For most of human history, losing muscle with age was not a big worry; by the time your biceps began to shrink, something else had likely caused your death. However, in a world where we routinely outlive our hunter-gatherer ancestors, muscle loss is a serious problem [19].

Aging muscles aren’t just weaker; they fatigue faster, recover slower, and burn energy less efficiently. At the core of this decline are mitochondria going on strike.

Without working mitochondria, muscle fibers have a hard time making energy. This results in less endurance, slower repair, and a greater chance of sedentary behavior [20]. Researchers started to wonder if urolithin A can help with mitochondrial function. They wondered if it could slow down or even reverse age-related muscle decline. Of course, this isn’t a steroid that will turn a 70-year-old into a sprinter overnight, but in clinical trials, something intriguing happened.

A randomized, placebo-controlled study had older adults take urolithin A for four months [21]. They walked farther, cycled longer, and reported less fatigue in daily life. The improvements weren’t massive, but they were measurable: about 12% better than placebo. Considering that many of these participants were already in decent shape, that’s not insignificant.

Strength, on the other hand, is a more complicated story. The researchers noted that endurance improved, but raw muscle strength didn’t rise significantly [21]. This suggests that urolithin A impacts the energy systems that fuel muscles. However, it does not directly make them bigger or stronger [21].

This has a simple explanation: the mitochondria in these aging muscle cells aren’t dead, they’re just inefficient. What urolithin A appears to do is clean out the sluggish, damaged mitochondria, making the remaining ones run better. Urolithin A doesn’t bulk muscle up, it just keeps the engine tuned [22].

These results were not as impressive as in mouse studies, but humans are not mice. Our biology is messier, often responds differently, and is more resistant to single-molecule miracles. What works beautifully in a rodent might produce quieter, subtler effects in a person, more like a gentle nudge toward keeping aging muscles functional for longer.

Inflammation and immunity

Aging isn’t just about gray hair and creaky joints, it’s a full-body biochemical revolt, and at the center of this slow-motion insurrection sits chronic inflammation.

Short-term inflammation is beneficial. You cut yourself, your immune system goes into high alert, and within days, the wound heals. However, with aging, this once-accurate system acts like a broken car alarm. It goes off constantly, even when there is no real danger.

This persistent, low-grade inflammation has a name: inflammaging [23, 24]. It’s the cellular equivalent of a smoldering fire, as it quietly damages tissues, promotes rather than prevents the onset of disease, and generally makes sure that aging feels as unpleasant as possible.

The NF-κB.pathway works like a cellular emergency dispatcher. When NF-κB is activated, it starts a series of inflammatory responses. It calls in cytokines like TNF-α, IL-1β, and IFN-γ, which signal your immune system to enter attack mode [25].

Studies suggest that urolithin A doesn’t shut down inflammation entirely, which would be a terrible idea. Instead, it fine-tunes it, reducing unnecessary immune overreactions without suppressing the system entirely. This results in less cellular stress, fewer inflammatory molecules floating around, and an immune system that isn’t constantly stuck on red alert.

In clinical trials, people taking urolithin A showed lower levels of inflammatory cytokines, particularly TNF-α and IL-1β. These two molecules are linked to age-related inflammation. This suggests that urolithin A is both a mitochondrial booster and an immune modulator [26, 27].

However, the data isn’t uniform across the board. While some inflammatory markers drop, others, like C-reactive protein (CRP), a broad indicator of systemic inflammation, barely budge.

This shows that urolithin A is not a universal anti-inflammatory drug; instead, it targets specific pathways involved in aging, and that’s a good thing [28, 29]. You don’t want to turn off inflammation completely; you just want to keep it from slowly wrecking everything in the background.

Chronic inflammation plays a major role in cardiovascular disease, cognitive decline, metabolic disorders, and muscle loss, all of which are significant effects of aging. If urolithin A can help quiet down inflammaging, even modestly, that may have significant effects on healthspan. However, inflammation isn’t the only system that urolithin A interacts with.

The gut microbiome

The human gut is a crowded place that contains trillions of microbes, including bacteria, viruses, and fungi. They break down food, produce metabolites, and affect digestion, mood, and immune function.

It’s less like a single organ and more like a teeming microbial ecosystem, where balance is everything. This bacterial ecosystem is known as the microbiome.

Current research has found that bypassing urolithin A metabolism through direct supplementation does not harm gut microbial balance. In clinical studies, people taking urolithin A didn’t experience dramatic shifts in their gut bacteria. There were no mass extinctions and no radical reconfigurations of their microbiome [30].

Additionally, there’s no evidence that supplementing urolithin A causes the microbiome to stop producing it or become dependent on it, at least in the short term. However, no long-term study has been conducted to make sure.

Side effects

There are few avaiable shortcuts in biology. Molecules that do interesting things can sometimes have unintended consequences. So far, urolithin A seems to be an exception.

In multiple human trials, people taking urolithin A showed no significant side effects. Liver function stayed normal, kidney markers remained unchanged, and there were no unexpected shifts in cardiovascular health.

Participants tolerated it well, with no concerning reports of toxicity, discomfort, or metabolic disruptions. If anything, researchers were pleasantly surprised by how uneventful the safety data turned out to be [31].

That said, no molecule is completely free of risk. While short-term studies have been reassuring, long-term data is also lacking in this area. Small biological changes, which may not appear after a few months but could show up after years, are possible.

Urolithin A’s interactions with other medications and dietary factors have not been thoroughly explored, however. Since it affects mitochondrial function and inflammation, it might increase or reduce the effects of other, similar, compounds. No red flags have shown up yet. However, especially in older people, small biochemical interactions can sometimes cause unexpected results.

Many compounds that show promise in aging research come with trade-offs, making them effective but impractical due to side effects. Urolithin A, on the other hand, appears to deliver modest but meaningful benefits without obvious drawbacks.

For now, the data suggests that it’s safe, well-tolerated, and unlikely to cause harm when taken as directed. The real test will come with longer studies and larger groups of people. We also need to see how it fits into the bigger picture of aging interventions.

Until then, it remains one of the more promising molecules in the pursuit of healthier aging. It isn’t going to be a miracle molecule, but it is a practical step in the right direction.

Impact of the Natural Compound Urolithin A on Health, Disease, and Aging [32]

A step toward reduced aging

Urolithin A is one of the more intriguing discoveries in this space, as it targets something fundamental: mitochondrial decline, a process tied to muscle endurance, inflammation, and overall cellular health.

The research so far suggests that it helps cells clear out damaged mitochondria. This improves energy efficiency and resilience over time. In human studies, those benefits translate into better endurance, improved mitochondrial function, and subtle but measurable reductions in inflammatory markers.

Disclaimer

This article is only a very brief summary and is not intended as an exhaustive guide. It is based on the interpretation of research data, which is speculative by nature. This article is not a substitute for consulting your physician about which supplements may or may not be right for you. We do not endorse supplement use or any product or supplement vendor.

Literature

[1] Pahl, K.P. Life Expectancy in Ancient and Modern Man. Acta Anthropogenet 1981, 5, 119–128.

[2] Levine, M.E.; Lu, A.T.; Quach, A.; Chen, B.H.; Assimes, T.L.; Bandinelli, S.; Hou, L.; Baccarelli, A.A.; Stewart, J.D.; Li, Y.; et al. An Epigenetic Biomarker of Aging for Lifespan and Healthspan. Aging (Albany NY) 2018, 10, 573.

[3] Zhang, M.; Cui, S.; Mao, B.; Zhang, Q.; Zhao, J.; Zhang, H.; Tang, X.; Chen, W. Ellagic Acid and Intestinal Microflora Metabolite Urolithin A: A Review on Its Sources, Metabolic Distribution, Health Benefits, and Biotransformation. Crit Rev Food Sci Nutr 2023, 63, 6900–6922.

[4] Wojciechowska, O.; Kujawska, M. Urolithin A in Health and Diseases: Prospects for Parkinson’s Disease Management. Antioxidants 2023, 12, 1479.

[5] Liu, S.; D’Amico, D.; Shankland, E.; Bhayana, S.; Garcia, J.M.; Aebischer, P.; Rinsch, C.; Singh, A.; Marcinek, D.J. Effect of Urolithin a Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Netw Open 2022, 5, doi:10.1001/jamanetworkopen.2021.44279.

[6] Amara, C.E.; Shankland, E.G.; Jubrias, S.A.; Marcinek, D.J.; Kushmerick, M.J.; Conley, K.E. Mild Mitochondrial Uncoupling Impacts Cellular Aging in Human Muscles in Vivo. Proc Natl Acad Sci U S A 2007, 104, 1057–1062.

[7] Kuerec, A.H.; Lim, X.K.; Khoo, A.L.; Sandalova, E.; Guan, L.; Feng, L.; Maier, A.B. Targeting Aging with Urolithin A in Humans: A Systematic Review. Ageing Res Rev 2024, 100, 102406.

[8] Salminen, J.P. The Chemistry and Chemical Ecology of Ellagitannins in Plant–Insect Interactions: From Underestimated Molecules to Bioactive Plant Constituents. Recent Advances in Polyphenol Research 2014, 4, 83–113.

[9] Pidgeon, R.; Mitchell, S.; Shamash, M.; Suleiman, L.; Dridi, L.; Maurice, C.F.; Castagner, B. Diet-Derived Urolithin A Is Produced by a Dehydroxylase Encoded by Human Gut Enterocloster Species. Nature Communications 2025 16:1 2025, 16, 1–18.

[10] Tomás-Barberán, F.A.; García-Villalba, R.; González-Sarrías, A.; Selma, M. V.; Espín, J.C. Ellagic Acid Metabolism by Human Gut Microbiota: Consistent Observation of Three Urolithin Phenotypes in Intervention Trials, Independent of Food Source, Age, and Health Status. J Agric Food Chem 2014, 62, 6535–6538.

[11] Cortés-Martín, A.; García-Villalba, R.; González-Sarrías, A.; Romo-Vaquero, M.; Loria-Kohen, V.; Ramírez-De-Molina, A.; Tomás-Barberán, F.A.; Selma, M. V.; Espín, J.C. The Gut Microbiota Urolithin Metabotypes Revisited: The Human Metabolism of Ellagic Acid Is Mainly Determined by Aging. Food Funct 2018, 9, 4100–4106.

[12] Spinelli, J.B.; Haigis, M.C. The Multifaceted Contributions of Mitochondria to Cellular Metabolism. Nature Cell Biology 2018 20:7 2018, 20, 745–754.

[13] Liang, X.F.; Poulton, J.; Lechuga-Vieco, A.V. Role of Mitophagy and Mitochondria in Aging and Cellular Senescence. Mitophagy in Health and Disease: Mechanisms, Health Implications, and Therapeutic Opportunities 2025, 143–168.

[14] Seo, A.Y.; Joseph, A.M.; Dutta, D.; Hwang, J.C.Y.; Aris, J.P.; Leeuwenburgh, C. New Insights into the Role of Mitochondria in Aging: Mitochondrial Dynamics and More. J Cell Sci 2010, 123, 2533–2542.

[15] Andreux, P.A.; Blanco-Bose, W.; Ryu, D.; Burdet, F.; Ibberson, M.; Aebischer, P.; Auwerx, J.; Singh, A.; Rinsch, C. The Mitophagy Activator Urolithin A Is Safe and Induces a Molecular Signature of Improved Mitochondrial and Cellular Health in Humans [J]. Nat Metab 2019, 1, 595–603.

[16] Ryu, D.; Mouchiroud, L.; Andreux, P.A.; Katsyuba, E.; Moullan, N.; Nicolet-Dit-Félix, A.A.; Williams, E.G.; Jha, P.; Lo Sasso, G.; Huzard, D.; et al. Urolithin A Induces Mitophagy and Prolongs Lifespan in C. Elegans and Increases Muscle Function in Rodents. Nature Medicine 2016 22:8 2016, 22, 879–888.

[17] Moussa, M.R.; Fan, N.; Birk, J.; Provatas, A.A.; Mehta, P.; Hatano, Y.; Chun, O.K.; Darooghegi Mofrad, M.; Lotfi, A.; Aksenov, A.; et al. Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A. Cancer Prevention Research 2025, OF1–OF16.

[18] Chen, K.; Ying, J.; Zhu, J.; Chen, L.; Liu, R.; Jing, M.; Wang, Y.; Zhou, K.; Wu, L.; Wu, C.; et al. Urolithin A Alleviates NLRP3 Inflammasome Activation and Pyroptosis by Promoting Microglial Mitophagy Following Spinal Cord Injury. Int Immunopharmacol 2025, 148, 114057.

[19] Kirk, B.; Cawthon, P.M.; Arai, H.; Ávila-Funes, J.A.; Barazzoni, R.; Bhasin, S.; Binder, E.F.; Bruyere, O.; Cederholm, T.; Chen, L.K.; et al. The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing 2024, 53.

[20] Anagnostou, D.; Theodorakis, N.; Hitas, C.; Kreouzi, M.; Pantos, I.; Vamvakou, G.; Nikolaou, M. Sarcopenia and Cardiogeriatrics: The Links Between Skeletal Muscle Decline and Cardiovascular Aging. Nutrients 2025, Vol. 17, Page 282 2025, 17, 282.

[21] Singh, A.; D’Amico, D.; Andreux, P.A.; Fouassier, A.M.; Blanco-Bose, W.; Evans, M.; Aebischer, P.; Auwerx, J.; Rinsch, C. Urolithin A Improves Muscle Strength, Exercise Performance, and Biomarkers of Mitochondrial Health in a Randomized Trial in Middle-Aged Adults. Cell Rep Med 2022, 3.

[22] Li, M.; Qin, Y.; Geng, R.; Fang, J.; Kang, S.-G.; Huang, K.; Tong, T.; Li, M.; Qin, Y.; Geng, R.; et al. Effects and Mechanisms of Phytochemicals on Skeletal Muscle Atrophy in Glucolipid Metabolic Disorders Current Evidence and Future Perspectives. Food Innovation and Advances 2025 1: 2025, 4, 83–98.

[23] Franceschi, C.; Garagnani, P.; Parini, P.; Giuliani, C.; Santoro, A. Inflammaging: A New Immune–Metabolic Viewpoint for Age-Related Diseases. Nat Rev Endocrinol 2018, 14, 576–590.

[24] Barkovskaya, A.; Brauning, A.; Chamoli, M.; Rane, A.; Andersen, J.K.; Sharma, A. Mitigating Proinflammatory SASP and DAMP with Urolithin A: A Novel Senomorphic Strategy. bioRxiv 2025, 2025.01.07.631588.

[25] Chen, P.; Wu, L.; Lei, J.; Chen, F.; Feng, L.; Liu, G.; Zhou, B. The Ellagitannin Metabolite Urolithin C Attenuated Cognitive Impairment by Inhibiting Neuroinflammation via Downregulation of MAPK/NF-KB Signaling Pathways in Aging Mice. Int Immunopharmacol 2024, 142, 113151.

[26] Fu, X.; Gong, L.F.; Wu, Y.F.; Lin, Z.; Jiang, B.J.; Wu, L.; Yu, K.H. Urolithin A Targets the PI3K/Akt/NF-ΚB Pathways and Prevents IL-1β-Induced Inflammatory Response in Human Osteoarthritis: In Vitro and in Vivo Studies. Food Funct 2019, 10, 6135–6146.

[27] Giménez-Bastida, J.A.; González-Sarrías, A.; Larrosa, M.; Tomás-Barberán, F.; Espín, J.C.; García-Conesa, M.T. Ellagitannin Metabolites, Urolithin A Glucuronide and Its Aglycone Urolithin A, Ameliorate TNF-α-Induced Inflammation and Associated Molecular Markers in Human Aortic Endothelial Cells. Mol Nutr Food Res 2012, 56, 784–796.

[28] Moussa, M.R.; Fan, N.; Birk, J.; Provatas, A.A.; Mehta, P.; Hatano, Y.; Chun, O.K.; Darooghegi Mofrad, M.; Lotfi, A.; Aksenov, A.; et al. Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A. Cancer Prevention Research 2025, OF1–OF16.

[29] Zhao, H.; Zhu, H.; Yun, H.; Liu, J.; Song, G.; Teng, J.; Zou, D.; Lu, N.; Liu, C. Assessment of Urolithin A Effects on Muscle Endurance, Strength, Inflammation, Oxidative Stress, and Protein Metabolism in Male Athletes with Resistance Training: An 8-Week Randomized, Double-Blind, Placebo-Controlled Study. J Int Soc Sports Nutr 2024, 21, 2419388.

[30] Nishimoto, Y.; Fujisawa, K.; Ukawa, Y.; Kudoh, M.; Funahashi, K.; Kishimoto, Y.; Fukuda, S. Effect of Urolithin A on the Improvement of Vascular Endothelial Function Depends on the Gut Microbiota. Front Nutr 2023, 9, 1077534.

[31] Kuerec, A.H.; Lim, X.K.; Khoo, A.L.; Sandalova, E.; Guan, L.; Feng, L.; Maier, A.B. Targeting Aging with Urolithin A in Humans: A Systematic Review. Ageing Res Rev 2024, 100, 102406

[32] D’Amico, D.; Andreux, P.A.; Valdés, P.; Singh, A.; Rinsch, C.; Auwerx, J. Impact of the Natural Compound Urolithin A on Health, Disease, and Aging. Trends Mol Med 2021, 27, 687–699.